About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lung Cancer Clinical Trials | 7,992 Studies Recruiting

Clinical TrialsLung Cancer

Lung Cancer Clinical Trials

Browse 7,992 clinical trials for lung cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3821-3840 of 7,992 trials

RecruitingProSpecTive sAmpling in dRiver muTation Pulmonary Oncology Patients on Tyrosine Kinase Inhibitors (START-TKI)The study is perfomed with adult patients with non-small cell lung cancer treated with tyrosine kinase inhibitor.NCT05221372·Rotterdam Active not recruitingPembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01)The main goals are after treatment given before surgery, to measure the number of people who have no signs of cancer cells in tumors and lymph nodes removed during surgery; and to…NCT06788912·Daphne, Alabama and 38 others

Related Searches

nsclctrials sclctrials lung carcinomatrials

Data from ClinicalTrials.govTerms

RecruitingFirst-line Therapy With Nivolumab Plus Ipilimumab in Combination With Chemotherapy for Metatastatic NSCLC (NICReWo Trial)NICReWo is an Italy-wide, multicenter, observational, ambispective study, designed to collect real-life data during the early post-market authorization approval period of the…NCT07190677·Pavia, Lombardy

RecruitingA Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)The purpose of this study is to assess the safety, tolerability, and efficacy of Imzokitug in combination with Pumitamig and Platinum-Doublet Chemotherapy (PDCT) versus Pumitamig…NCT07680764·Washington D.C., District of Columbia and 72 others

CompletedCombination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By SurgeryRandomized phase III trial to compare the effectiveness of combination chemotherapy plus radiation therapy with or without gefitinib in treating unresectable stage III non-small…NCT00020709·San Antonio, Texas

AvailableAn EAP Treatment Protocol of Zipalertinib"Only licensed physicians may submit an email inquiry/question about Taiho's Zipalertinib Expanded Access Program via email (Zipalertinib@parexel.com).NCT07601399

UnknownHyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic TumorsThermal therapy (hyperthermia, or heat) increases chemotherapy cancer cell kill. By itself, thermal therapy can also kill cancer cells.NCT00178698·Houston, Texas

UnknownStudy Comparing WX-0593 to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) PatientsThe primary purpose of this study is to evaluate the efficacy and safety of WX-0593 vs. crizotinib in patients with ALK-positive non-small cell lung cancer who had not received…NCT04632758·Beijing, Beijing Municipality

CompletedAutologous Tumor DRibble Vaccine in Patients With Non-Small Cell Lung CancerThis is a pilot single institution study of DRibble vaccination + GM-CSF in patients with stage IIIB or IV NSCLC who have undergone 0-1 chemotherapy regimens for metastatic…NCT00850785·Portland, Oregon

CompletedLocally Advanced NSCLC Hyperfractionated RTThis is a prospective phase II study designed to evaluate an accelerated and adaptive RT approach for locally-advanced non-small cell lung cancer (NSCLC).NCT03128008·Durham, North Carolina

CompletedEffects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung CancerThe purpose of this study is to find better treatment for lung cancer and to find out what effects the combined treatment of carboplatin and gemcitabine when given with or without…NCT00247416·Danville, Kentucky and 6 others

Not yet recruitingPHOENIX: QL1706 Plus Chemotherapy and Bevacizumab in AGA-Resistant, PD-L1 ≥50% Non-Squamous NSCLCThe goal of this Phase II clinical trial (The PHOENIX Study) is to evaluate if the combination of QL1706 (Iparomlimab and Tuvonralimab), bevacizumab, and chemotherapy can treat…NCT07416058

CompletedINS316 in Diagnosing Lung Cancer in Patients With Untreated Lung CancerRATIONALE: Doctors can diagnose lung cancer by collecting mucus coughed up from the lungs and examining it under a microscope to look for cancer cells.NCT00008255·New York, New York

TerminatedA Study of TAS3351 in NSCLC Patients With EGFRmtThis is a first-in-human, open label, Phase 1/2 study to investigate the safety and efficacy of TAS3351 in participants with advanced or metastatic non-small cell lung cancer…NCT05765734·Nashville, Tennessee and 7 others

RecruitingDose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid TumorsThe primary purpose of this study is to determine the safety, tolerability, and maximum tolerated dose (MTD) of EXS74539 (REC-4539) in participants with select solid tumors.NCT07517198·Los Angeles, California and 2 others

CompletedStudy of Enzastaurin Versus Placebo With Pemetrexed for Participants With Advanced or Metastatic Lung CancerThe purpose of this study is to determine if the combination of enzastaurin and pemetrexed can extend survival time without progression of disease for participants who have…NCT00530621·Fayetteville, Arkansas and 24 others

UnknownHistocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung CancerThe purpose of this study is to evaluate the safety and time to progression of HLA-A\*2402 restricted epitope peptides URLC10, TTK and KOC1 emulsified with Montanide ISA 51.NCT00674258·Tokyo, Tokyo

RecruitingA Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid TumorsThe purpose of this study is to evaluate the safety, tolerability, pharmacokinetic, pharmacodynamic, preliminary anti-tumor activity, and to determine the recommended Phase II…NCT06747585·Scottsdale, Arizona and 40 others

UnknownPLAsma Genomic Testing in Patients With Advanced Non-Small Cell Lung Cancer: The PLAN StudyThis is a multi-centre, prospective, translational study investigating the use of plasma genotyping for initial genomic testing in newly diagnosed advanced/locally advanced…NCT05542485·Dublin and 2 others

CompletedToripalimab Combined With Double Platinum-based Chemotherapy for Initially Unresectable NSCLCThe aim of the study was to investigate the efficacy of Toripalimab Combined with Double Platinum Based Chemotherapy for Initially Unresectable Non-driver Gene Mutation Non-small…NCT04144608·Changsha, Hunan

PreviousPage 192 of 400Next